AI-Based Speech Intelligibility Assessment: Efficacy & Reliability

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPusan National University Yangsan Hospital

About this trial

compare the auditory-perceptual assessment conducted by speech-language pathologists using the U-TAP with the assessment performed via the AI solution (Blings) program in patients with speech disorders, and to evaluate the efficacy and reliability of these two methods for speech intelligibility assessment.

Eligibility criteria

Qualifiers

Adults aged 18 years or older.

Patients with neurologic disorders, including amyotrophic lateral sclerosis, poliomyelitis, cerebellar disorders, cerebellar lesions, and stroke.

Patients presenting with concomitant speech disorders, such as dysarthria, motor speech disorders, and voice disorders.

Disqualifiers

Subjects with a score of less than 16 points on the Korean Mini-Mental State Examination (K-MMSE).

Subjects with visual, perceptual, or auditory impairments that prevent them from following the examiner's instructions.

Subjects judged by the researcher as unsuitable for participation in this clinical study due to other reasons.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

40 Participants
are grouped into 1 trial group

Locations

This trial has no locations